Zydus Cadila seeks emergency use approval of COVID-19 vaccine
The Hindu
Drugmaker Zydus Cadila said on Thursday it has applied to the country’s drug regulator for emergency use approval of its COVID-19 vaccine,which showed a 66.6% efficacy against positive cases in an int
Drugmaker Zydus Cadila said on Thursday it has applied to the country’s drug regulator for emergency use approval of its COVID-19 vaccine,which showed a 66.6% efficacy against positive cases in an interim analysis. The candidate, if approved, would become India’s second successful home-grown COVID-19 shot and help ease the country’s severe vaccine shortage. the vaccine, which is a three-course regimen, showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in the12-18-year age group.More Related News